A direct control of MICA by the BCR/ABL oncogene in chronic myelogenous leukemia had been described [16], while the HER2-HER3 signalling was involved in the regulation of MICA/B expression in breast cancer cell lines [17, 18]. Here, ERBB3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.